Evidence map›Paper›PMID 23738299›Full record

ArticleMuscles, ligaments and tendons journal2012

The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?

Ciro Tetta, Anna Lange Consiglio, Stefania Bruno, Emanuele Tetta, Emanuele Gatti, Miryana Dobreva, Fausto Cremonesi, Giovanni Camussi

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Muscles, ligaments and tendons journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03514537 (Use of Autologous Stem/Stromal Cellular Stromal Vascular Fraction), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03514537 nasuspendednot on this mapstarted 2018, after this paper: background citation

Use of Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Cases Of Frailty and Aging Processes Using Autologous Stem-Stromal Cell Infusion in Patients With Aging Frailty And Wellness

TypeinterventionalSponsorHealeon Medical IncRan2018 to 2028Enrolled200ConditionsFrail Elderly Syndrome, Aging, Degenerative DiseaseArmsMicrocannula harvest adipose stromal tissues, Centricyte 1000, Sterile Normal Saline IV Deployment of cSVF, Liberase, Saline Solution
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Current Progress in Tendon and Ligament Tissue Engineering.Tissue engineering and regenerative medicine · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ciro TettaCenter of Translational Regenerative Medicine, Fresenius Medical Care Deutschland GmbH, Torino, Italy.
Anna Lange Consiglio
Stefania Bruno
Emanuele Tetta
Emanuele Gatti
Miryana Dobreva
Fausto Cremonesi
Giovanni Camussi
Fresenius Medical Care (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tendon injuries represent even today a challenge as repair may be exceedingly slow and incomplete. Regenerative medicine and stem cell technology have shown to be of great promise. Here, we will review the current knowledge on the mechanisms of the regenerative potential of mesenchymal stem cells (MSCs) obtained from different sources (bone marrow, fat, cord blood, placenta). More specifically, we will devote attention to the current use of MSCs that have been used experimentally and in limited numbers of clinical cases for the surgical treatment of subchondral-bone cysts, bone-fracture repair and cartilage repair. Based on the recently emerging role in regenerative mechanisms of soluble factors and of extracellular vesicles, we will discuss the potential of non-cellular therapies in horse tendon injuries.

Indexed as

horse tendinopathiesmicrovesiclesregenerative medicinesoluble factorsstem cells

Identifiers

PMID23738299
PMCPMC3666529
OpenAlexW2096852436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.